Next Article in Journal
The Bright and Dark Sides of Nitric Oxide in Neurodegenerative Diseases
Next Article in Special Issue
Twelve-Month Real-World Outcomes of Tezepelumab in Severe Asthma: Clinical Remission, Biomarker Changes, and Trigger Burden—A SANI Multicenter Cohort
Previous Article in Journal
Development and Evaluation of a Radiomics-Based 3D Volumetric and Densitometric Tomographic Scoring System for Chronic Rhinosinusitis with Nasal Polyposis: A Comparative Analysis
Previous Article in Special Issue
Real-World Effectiveness of Tezepelumab in Severe Asthma: A Comparative Analysis of High and Low T2 Phenotypes
 
 
Article

Article Versions Notes

J. Pers. Med. 2026, 16(5), 245; https://doi.org/10.3390/jpm16050245
Action Date Notes Link
article html file updated 3 September 2026 16:11 CEST Update https://www.mdpi.com/2075-4426/16/5/245/html
article html file updated 13 May 2026 09:17 CEST Original file -
article pdf uploaded. 13 May 2026 09:15 CEST Updated version of record https://www.mdpi.com/2075-4426/16/5/245/pdf
article xml uploaded. 13 May 2026 09:15 CEST Update https://www.mdpi.com/2075-4426/16/5/245/xml
article xml file uploaded 13 May 2026 09:15 CEST Original file -
article pdf uploaded. 30 April 2026 19:25 CEST Version of Record https://www.mdpi.com/2075-4426/16/5/245/pdf-vor
Back to TopTop